Kiora Pharmaceuticals | EFFECT: Others
Mar 29 18:13
Kiora Pharmaceuticals | 424B3: Prospectus
Mar 29 04:51
CORRESP: CORRESP
Mar 27 00:58
Kiora Pharmaceuticals | DEF 14A: Definitive information statements
Mar 26 04:35
Kiora Pharmaceuticals | 8-K: Current report
Mar 25 19:08
Kiora Pharmaceuticals | 10-K: Annual report
Mar 25 19:03
Kiora Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 15 19:05
UPLOAD: Others
Mar 5 01:58
Kiora Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Feb 29 05:54
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%), etc.
Feb 15 06:02
Kiora Pharmaceuticals | D: Filing D
Feb 15 04:54
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Feb 14 09:12
Kiora Pharmaceuticals | 8-K: Current report
Feb 13 06:25
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
Feb 10 05:21
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.9%),Orin H(9.9%)
Feb 7 22:26
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.5%),Daniel B. Asher(1.5%), etc.
Feb 6 23:32
Kiora Pharmaceuticals | 8-K: Current report
Feb 1 20:06
Kiora Pharmaceuticals | 8-K: Current report
Feb 1 06:18
Kiora Pharmaceuticals | 8-K: Current report
Jan 16 13:00
Kiora Pharmaceuticals | 8-K: Current report
Nov 9, 2023 20:02
No Data
No Data